相关实验视频

Updated: May 3, 2026

Advanced Compositional Analysis of Nanoparticle-polymer Composites Using Direct Fluorescence Imaging

Advanced Compositional Analysis of Nanoparticle-polymer Composites Using Direct Fluorescence Imaging

Published on: July 19, 2016

光纳米复合材料具有协同效应,用于在糖尿病病治疗中增强利的输送

Suyu Wang¹, Yanyan Wu¹, Bingru Fei²

¹Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

Journal of fluorescence

|February 22, 2025

概括

研究人员开发了一种新的光探针 (化合物1) 和用于糖尿病病的药物输送系统. 该系统可实现实时药物跟踪,并增强治疗效果,对治疗病有前景.

科学领域:

材料科学材料科学材料科学
纳米技术纳米技术
生物医学工程生物医学工程

背景情况:

糖尿病病 (DN) 是一个重大的健康挑战,需要先进的治疗策略.
有效的药物输送系统对于提高治疗效率和监测DN等复杂疾病中的药物释放至关重要.
光探针为实时跟踪生物系统中的药物分布和释放动态提供了潜在的潜力.

研究的目的:

设计和合成一种用于药物追踪的新型光硫纯氨酸类似物 (化合物1).
开发一种基于铜 (II) 的协调聚合物 (CP1),以提高化合物1的可溶性和生物相容性.
创建一个复合药物输送系统 (mPEG-PSU@CP1@1@fenelidone) 用于在糖尿病病中协同治疗和实时监测.

主要方法:

合成了一种具有固有的光性的新型硫纯氨酸类比物 (化合物1).
3D铜(II) 协调聚合物的水热合成 (CP1).
在CP1和mPEG-PSU外中封装化合物1和利的复合药物输送系统的制造.
使用各种分析技术进行表征.
在体内研究使用糖尿病病模型小鼠.

主要成果:

化合物1显示出显著的光特性,适用于探头应用.
复合系统成功地联合封装了化合物1和利.
通过光火和恢复实现了药物释放的实时监测.
复合系统表现出协同治疗效应,减少DN小鼠的炎症和纤维化.
该系统展示了优化控制的药物释放和增强的治疗疗效.

结论:

开发的复合药物输送系统将实时光监测与糖尿病病症增强协同治疗相结合.
化合物1作为一个有效的光探针来跟踪药物释放.
mPEG-PSU@CP1@1@fenelidone系统为治疗糖尿病病提供了一个有前途的治疗策略.
这种方法突显了结合先进材料和光探针的潜力,以改善疾病治疗和监测.

关键词:

糖尿病脏病糖尿病脏病纳米载体纳米载体是什么有协同效应的效应.mPEG-PSU 的使用情况.

更多相关视频

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

相关概念视频

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...